Who Exports Cytarabine from India — 175 Suppliers Behind a $10.7M Market
India's cytarabine export market is supplied by 175 active exporters who collectively shipped $10.7M across 1,825 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 47.6% market share, followed by FRESENIUS KABI ONCOLOGY LIMITED and NAPROD LIFE SCIENCES PRIVATE LIMITED. The top 5 suppliers together control 77.2% of total export value, reflecting a concentrated market structure.
Top Cytarabine Exporters from India — Ranked by Export Value
INTAS PHARMACEUTICALS LIMITED is the leading cytarabine exporter from India, holding a 47.6% share of the $10.7M market across 1,825 shipments from 175 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED, ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED, CELON LABORATORIES PRIVATE LIMITED — collectively control 77.2% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (47.6%), FRESENIUS KABI ONCOLOGY LIMITED (16.9%), NAPROD LIFE SCIENCES PRIVATE LIMITED (5.2%), ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED (4.6%), CELON LABORATORIES PRIVATE LIMITED (2.9%).
Top Cytarabine Exporters from India
Ranked by export value · 175 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED PHARMA DRUGS AND MEDI CYTARABINE ACCORDPHARMA DRUGS & MEDI CYTARABINE INJ,100MGPHARMA DRUG&MED:CYTARABINE INJ BP 1000MG | $5.1M | 14 | 47.6% |
| 2 | FRESENIUS KABI ONCOLOGY LIMITED CYTARABINE FRESENIUS INJ. 500MG/5ML VIALCYTARINE INJ. 1GM/10ML VIAL,CYTARABINE CYTARABINE FRESENIUS INJ 500MG 5ML VIAL | $1.8M | 13 | 16.9% |
| 3 | NAPROD LIFE SCIENCES PRIVATE LIMITED CYTARABINE INJECTION BP 500MG/5ML VLSCYTARABINE INJECTION BP 500MG 5ML 29725VIALSZABINA 1G/10ML CYTARABINE INJECTION BP | $557.0K | 8 | 5.2% |
| 4 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED PHARMA DRUGS AND MEDI CYTARABINE ACCORDCYTARABINE INJ. 2G AU - F000046298 | $498.8K | 7 | 4.6% |
| 5 | CELON LABORATORIES PRIVATE LIMITED CANCYT 1000MG VLSCANCYT 1000MG/10MLCANCYT 100MG/1ML | $313.6K | 11 | 2.9% |
| 6 | RUS MED EXPORTS PVT. LTD. | $311.9K | 1 | 2.9% |
| 7 | UNITED BIOTECH PRIVATE LIMITED | $303.8K | 13 | 2.8% |
| 8 | MEDORBIS TRADE LLP CYTARABINE INJECTION BP 500MG/5ML VLSCYTARABINE INJECTION BP 500MG 5ML 29725VIALSZABINA 1G/10ML CYTARABINE INJECTION BP | $199.1K | 1 | 1.9% |
| 9 | VENUS REMEDIES LIMITED CYTARABINE INJECTION BP 500MG/5ML VLSCYTARABINE INJECTION BP 500MG 5ML 29725VIALSZABINA 1G/10ML CYTARABINE INJECTION BP | $186.7K | 7 | 1.7% |
| 10 | NV REMEDIES PRIVATE LIMITED | $181.6K | 3 | 1.7% |
| 11 | PLEASANT EXPORTS | $131.9K | 1 | 1.2% |
| 12 | MEDWISE OVERSEAS PRIVATE LIMITED | $70.4K | 2 | 0.7% |
| 13 | SWASTHYA HEALTHCARE PRIVATE LIMITED | $65.4K | 1 | 0.6% |
| 14 | VHB MEDI SCIENCES LIMITED | $59.7K | 3 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Cytarabine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Intas Pharmaceuticals Limited | Warning Letter, December | Yes, April 2007 | Yes | Not verified | Received EU GMP certification in April 2007; FDA issued a warning letter in Dece |
| Naprod Life Sciences Private Limited | Not verified | Yes | Not verified | Not verified | Listed as a WHO-GMP certified manufacturer by CDSCO. |
| Venus Remedies Limited | Not Listed | Yes | No | Not verified | Approved under India's Production Linked Incentive scheme for pharmaceuticals. |
| United Biotech Private Limited | Not Listed | Yes | No | Not verified | Participated in government tenders for pharmaceutical products. |
| Celon Laboratories Private Limited | Not Listed | Yes | No | Not verified | Supplied pharmaceutical products in government tenders. |
| Fresenius Kabi Oncology Limited | Not Listed | Yes | No | Not verified | Supplied pharmaceutical products in government tenders. |
| VHB Medi Sciences Limited | Not Listed | Yes | No | Not verified | Supplied pharmaceutical products in government tenders. |
| Zydus Hospira Oncology Private Limited | Not Listed | Yes | No | Not verified | Supplied pharmaceutical products in government tenders. |
TransData Nexus reviewed the regulatory standing of 8 leading Cytarabine exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 1 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Cytarabine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "India's pharmaceutical capital," has a rich history in bulk drug manufacturing. The establishment of Indian Drugs and Pharmaceuticals Limited (IDPL) in 1961 marked the city's foray into the pharmaceutical sector. By 2010, Hyderabad was responsible for producing one-third of India's bulk drugs and 16% of its biotechnology products. This robust infrastructure positions Hyderabad as a significant contributor to the production of active pharmaceutical ingredients (APIs) like Cytarabine.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent hub for pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports. The region is home to major pharmaceutical companies such as Intas Pharmaceuticals, Zydus Cadila Healthcare, and Alembic Pharmaceuticals. These companies have established advanced manufacturing facilities that produce a wide range of formulations, including injectable drugs like Cytarabine.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products. Mumbai, being a major port city, facilitates the export of pharmaceutical formulations to international markets. The region hosts several pharmaceutical companies with manufacturing units that produce and export a variety of drugs, including Cytarabine, to destinations such as the Netherlands, Brazil, and the United Kingdom.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, primarily due to favorable tax incentives. The region attracts numerous pharmaceutical companies that have set up manufacturing units to benefit from these incentives. While Baddi-Nalagarh is known for producing a range of pharmaceutical products, its contribution to Cytarabine production is less prominent compared to other clusters.
5Sourcing Recommendations
- Diversify Supplier Base: While Intas Pharmaceuticals Limited is the leading exporter of Cytarabine, accounting for 47.6% of exports, it's prudent to engage with other suppliers such as Fresenius Kabi Oncology Limited and Naprod Life Sciences Private Limited to mitigate supply chain risks.
- Leverage Gujarat's Manufacturing Capabilities: Given Gujarat's substantial share in drug manufacturing and exports, sourcing Cytarabine from companies based in Ahmedabad and Vadodara can ensure access to high-quality formulations.
- Utilize Mumbai's Export Infrastructure: Collaborating with manufacturers in the Mumbai-Thane-Raigad region can facilitate smoother logistics and export processes, especially for shipments destined for major international markets.
- Monitor Regulatory Compliance: Ensure that all suppliers comply with international regulatory standards, such as those set by the FDA, EMA, and WHO, to maintain product quality and facilitate market access.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Cytarabine exporters from India
Zydus Lifesciences Limited — Zydus acquires 50% stake in Sterling Biotech Limited
Zydus Lifesciences Limited, through its wholly owned subsidiary, acquired a 50% equity stake in Sterling Biotech Limited, a major pharmaceutical company specializing in gelatin, di-calcium phosphate, and select active pharmaceutical ingredients. - IMPACT: This acquisition is expected to enhance Zydus's production capabilities, potentially increasing Cytarabine exports.
Impact: This acquisition is expected to enhance Zydus's production capabilities, potentially increasing Cytarabine exports.
SeQuent Scientific Limited — SeQuent merges with Viyash Lifesciences to form leading animal health venture
SeQuent Scientific Limited and Viyash Lifesciences Private Limited announced a merger to create a platform with leadership in animal pharmaceuticals and expanded capabilities across the global pharmaceutical market. - IMPACT: While primarily focused on animal health, the merger may indirectly influence Cytarabine production through shared resources.
Impact: While primarily focused on animal health, the merger may indirectly influence Cytarabine production through shared resources.
Senores Pharmaceuticals — Senores acquires Apnar Pharma for ₹91 crore
Senores Pharmaceuticals announced the acquisition of a 100% stake in Apnar Pharma Private Limited for ₹91 crore, aiming to expand its pharmaceutical manufacturing capabilities. - IMPACT: This acquisition may enhance production capacity, potentially affecting Cytarabine export volumes.
Impact: This acquisition may enhance production capacity, potentially affecting Cytarabine export volumes.
Common Questions — Cytarabine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which cytarabine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 693 recorded shipments worth $5.1M. FRESENIUS KABI ONCOLOGY LIMITED (98 shipments) and NAPROD LIFE SCIENCES PRIVATE LIMITED (52 shipments) are also established high-volume exporters.
Q How many cytarabine manufacturers are there in India?
India has 175 active cytarabine exporters with a combined export market of $10.7M across 1,825 shipments to 110 countries. The top 5 suppliers hold 77.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for cytarabine from India?
Average FOB unit price: $5.99 per unit, ranging from $0.05 to $1266.33. Average shipment value: $5.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 175 verified Indian exporters of Cytarabine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,825 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 110 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,825 Verified Shipments
175 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists